João Leandro

João Leandro

Auto-generated profile, based on publicly available information

João Leandro

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
AMAnia C. Muntau
Ania C. Muntau
JLJoão Leandro
João Leandro
MSMichael Staudigl
Michael Staudigl
FMFelix Mayer
Felix Mayer
SGSøren W. Gersting
Søren W. Gersting

16 January 2019 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
JLJoão Leandro
João Leandro
SHSander Michel Houten
Sander Michel Houten
Saccharopine, a nonproteinogenic amino acid originally isolated from the yeast Saccharomyces cerevisiae, is an intermediate in lysine metabolism. In this issue, Zhou et al. (2019. J. Cell Biol.https://doi.org./10.1083/jcb.201807204) show that abnormal accumulation of saccharopine results in defective mitochondrial dynamics and function in worm and mouse models.

8 May 2020 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
JLJoão Leandro
João Leandro
TDTetyana Dodatko
Tetyana Dodatko
JAJan Aten
Jan Aten
NNNatalia Nemeria
Natalia Nemeria
XZXu Zhang
Xu Zhang
SHSander Michel Houten
Sander Michel Houten
Glutaric aciduria type 1 (GA1) is an inborn error of lysine degradation characterized by a specific encephalopathy that is caused by toxic accumulation of lysine degradation intermediates. Substrate reduction through inhibition of DHTKD1, an enzyme upstream of the defective glutaryl-CoA dehydrogenase, has been investigated as a potential therapy, but revealed the existence of an alternative enzymatic source of glutaryl-CoA. Here, we show that loss of DHTKD1 in glutaryl-CoA dehydrogenase-deficient HEK-293 cells leads to a 2-fold decrease in the established GA1 clinical biomarker glutarylcarnitine and demonstrate that oxoglutarate dehydrogenase (OGDH) is responsible for this remaining glutarylcarnitine production. We furthermore show that DHTKD1 interacts with OGDH, dihydrolipoyl succinyltransferase and dihydrolipoamide dehydrogenase to form a hybrid 2-oxoglutaric and 2-oxoadipic acid dehydrogenase complex. In summary, 2-oxoadipic acid is a substrate for DHTKD1, but also for OGDH in a cell model system. The classical 2-oxoglutaric dehydrogenase complex can exist as a previously undiscovered hybrid containing DHTKD1 displaying improved kinetics towards 2-oxoadipic acid.

31 May 2006 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
JLJoão Leandro
João Leandro
CNCátia Nascimento
Cátia Nascimento
IAIsabel Tavares de Almeida
Isabel Tavares de Almeida
PLPaula Leandro
Paula Leandro

21 June 2020 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
JLJoão Leandro
João Leandro
TDTetyana Dodatko
Tetyana Dodatko
RDRobert J. DeVita
Robert J. DeVita
HCHongjie Chen
Hongjie Chen
BSBrandon Stauffer
Brandon Stauffer
SHSander Michel Houten
Sander Michel Houten

1 May 2011 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
JLJoão Leandro
João Leandro
PLPaula Leandro
Paula Leandro
TFTorgeir Flatmark
Torgeir Flatmark